Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
Clinical trial NCT00720941 · COMPLETED
Trial details
- NCT number
- NCT00720941
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-14
- Primary completion
- 2012-05-21
- Enrollment
- 1110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.